<unk> , or Ga<unk> <unk> -11, is a radiopharmaceutical made of<unk> Ga conjugated to prostate-specific membrane antigen <unk>  targeting ligand, Glu-Urea-Lys(Ahx)-HBED-CC, used for imaging prostate cancer by positron emission tomography (PET). The<unk>  targeting ligand specifically directs the radiolabeled imaging agent towards the prostate cancerous lesions in men. This is the first drug approved by USFDA as a PET imaging agent.
Gallium 68 PSMA-11
DOTA-TATE
Radium-223
FUB-APINACA
NCCERT
Fluorodeoxyglucose 
Iodine-131
Strontium-90